Insider Trading & Ownership of Morningside Venture Investments Ltd

Location
Newton Centre, MA
Summary
The estimated value of insider holdings of Morningside Venture Investments Ltd is at least $898,985,563 dollars as of 17 Aug 2023. Morningside Venture Investments Ltd is the 10%+ Owner of Apellis Pharmaceuticals, Inc. and owns shares of Apellis Pharmaceuticals, Inc. (APLS) stock worth about $815.64M. Morningside Venture Investments Ltd is the 10%+ Owner of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $81.6M. Morningside Venture Investments Ltd is the 10%+ Owner of Kezar Life Sciences, Inc. and owns shares of Kezar Life Sciences, Inc. (KZR) stock worth about $1.75M.
Signature
/s/ Frances Anne Elizabeth Richard, Director
All Insider Reports
All Insider Reports

Notify me when Morningside Venture Investments Ltd files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Morningside Venture Investments Ltd

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APLS Apellis Pharmaceuticals, Inc. 10%+ Owner $815,635,922 18 Nov 2021
AMLX Amylyx Pharmaceuticals, Inc. 10%+ Owner $81,596,447 15 Aug 2023
KZR Kezar Life Sciences, Inc. 10%+ Owner $1,753,194 15 Aug 2023
GRNA GreenLight Biosciences Holdings, PBC 10%+ Owner 24 Jul 2023

Insider Transactions Reported by Morningside Venture Investments Ltd:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.